Market Overview

Benzinga's Top Pre-Market Gainers

Related KORS
Luxury Update: Morgan Stanley Still Loves Michael Kors Despite 50% Year-To-Date Decline
Stocks Look Set To Pull Back Amid Mixed Earnings, Oil Trade, Fed
Related BMRN
BioMarin Pharma Crashed This Week, So Why Is This Mega-Bank Still Bullish?
FDA Advisory Committee Discusses Clinical Data Package for BioMarin's Kyndrisa for Treatment of Duchenne Muscular Dystrophy Amenable to Exon 51 Skipping
FDA Panel Seen As Bad For BioMarin, Good For Sarepta (Investor's Business Daily)

Michael Kors Holdings Ltd (NYSE: KORS) surged 13.41% to $43.30 in the pre-market session. Michael Kors reported a rise in its fourth-quarter profit.

BioMarin Pharmaceutical Inc (NASDAQ: BMRN) added 7.04% to $38.16 in the pre-market session. BMRN's trailing-twelve-month revenue is $448.55 million.

Arena Pharmaceuticals Inc (NASDAQ: ARNA) moved up 2.47% to $7.25 in the pre-market session. ARNA shares have surged 444.62% over the past 52 weeks, while the S&P 500 index has gained 1.64% in the same period.

Juniper Networks Inc (NYSE: JNPR) soared 2.13% to $16.75 in the pre-market trading. Juniper Networks approved a plan to buy back up to $1 billion of its own stock.

Posted-In: Top Pre-Market GainersNews Pre-Market Outlook Markets Movers


Related Articles (ARNA + BMRN)

View Comments and Join the Discussion!

Get Benzinga's Newsletters